“High Treg” Inflammations Promote (Most) Non-Hematologic Cancers While “Low Treg” Inflammations Promote Lymphoid Cancers
Zeev Elkoshi Research and Development Department, Taro Pharmaceutical Industries Ltd, Haifa, IsraelCorrespondence: Zeev Elkoshi Email zeev.elkoshi@gmail.comAbstract: In an earlier publication, a binary classification of chronic diseases has been proposed. Chronic diseases were classified as &ldq...
Guardado en:
Autor principal: | Elkoshi Z |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e9a1efc1351e4bdc9181b2aee5038157 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
IMMUNOLOGICAL MEMORY: THE ROLE OF REGULATORY CELLS (TREGS)
por: E. K. Oleinik, et al.
Publicado: (2018) -
SIGNIFICANCE OF Treg CELLS FOR ADENOSINE-MEDIATED IMMUNE SUPPRESSION IN COLORECTAL CANCER
por: G. A. Zhulai, et al.
Publicado: (2017) -
Kartogenin inhibits pain behavior, chondrocyte inflammation, and attenuates osteoarthritis progression in mice through induction of IL-10
por: Ji Ye Kwon, et al.
Publicado: (2018) -
The abnormal level of HSP70 is related to Treg/Th17 imbalance in PCOS patients
por: Yiqing Yang, et al.
Publicado: (2021) -
All Toyota Tribological Innovation to Realize “Zeronize” and “Maximize” Society
por: Shuhei Toyoda
Publicado: (2007)